Novartis AG's top executive said on Wednesday it expects to price its gene ...
FILE PHOTO: The logo of Swiss drugmaker Novartis AG is seen at its headquarters in Basel, Switzerland January 25, 2017. REUTERS/Arnd Wiegmann
U.S. regulators are expected to make a decision this month on whether to approve Zolgensma, a one-time therapy seen as a potential long-term solution for the rare disease that is the leading genetic cause of death in infants. The company has previously said it could price the treatment in a range of $1.5 million to $5 million.
The current treatment for SMA, which can lead to paralysis, breathing difficulty and early death, is Biogen Inc’s Spinraza. That drug has a list price of $750,000 for the initial year and $375,000 annually thereafter.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Commentary: Novartis CEO says gene therapies promise to upend US health system, pricing structureThe current global health system treats chronic diseases with a pay-as-you-go model, spreading costs over months and years. It's unprepared to pay for a surge of new, single-treatment therapies with the potential to provide a lifetime of benefit.
Read more »
Novartis CEO says cannabis isn't a focus despite Tilray partnershipNovartis CEO Vas Narasimhan said Tuesday that cannabis is not a priority for the Swiss drugmaker, despite its partnership with Canadian marijuana giant Tilray. HealthyReturns
Read more »
How WeWork's CEO manages his ego after going from broke to a billionaire in under 10 yearsWeWork CEO and cofounder Adam Neumann found his ego getting too big after the co-working space reached a $5 billion valuation.
Read more »
Verizon CEO: 'Tens of thousands' of customers buying new 5G phonesVerizon is betting that customers will pay up for Samsung's new 5G smartphone.
Read more »
SoFi CEO reveals what he learned about millennial stock investing habitsEarly investors are showing 'that they don't want to put a lot of money at risk,' SoFi CEO Anthony Soto says.
Read more »
Lloyds defends CEO pay after investor anger at annual investor meetingLloyds Banking Group has defended the 6.3 million pound ($8.06 million) pay pack...
Read more »
Taylor Morrison CEO on homebuilding at end of 2018: 'It was that bad.'The latest read on April housing starts showed improvement over March, but still a slower building pace than a year ago. The CEO of Arizona-based Taylor Morrison said, 'In December, if you were to talk to anybody, there was, potentially, a house was never going to be sold in the U.S. again. It was that bad.'
Read more »
Ex-Goldman Sachs CEO takes jab at NYC mayor over TwitterEx-Goldman Sachs CEO Lloyd Blankfein takes a jab at NYC Mayor Bill de Blasio on Twitter: 'On the bright side, if DeB gets elected prez, we New Yorkers will lose his undivided attention a year ahead of schedule'
Read more »
Singapore Airlines' order of 31 Boeing 737 Max jets remains 'intact,' CEO saysSingapore Airlines CEO Goh Choon Phong told reporters and analysts on Friday that an order for 31 Boeing 737 Max jets remains 'intact' despite the aircraft's two deadly crashes.
Read more »
Total CEO says planned buy of Anadarko's Africa assets 'perfectly fitting'French energy giant Total SA's planned acquisition of U.S. firm Anadarko&0...
Read more »
Rockstar CEO Aims To Amp Up 128-Year-Old Energy Drinks BusinessLast October, Petch led 128-year-old Osotspa in the country’s biggest IPO of the year, raising a $464 million war chest for expansion from a 20% stake that valued the company at $2.3 billion.
Read more »